Fanconi anemia complementation group E: clinical and cytogenetic data of the first patient.
The clinical and cytogenetic data of the first patient proven to belong to the fifth Fanconi anemia complementation group are described. The Turkish boy presented with psychomotoric retardation, growth retardation, retarded bone age, brachycephaly, hypotelorism, epicanthus, syndactyly, brachydactyly, renal dystopia, and cryptorchism. In addition, an asymmetrical skeletal anomaly was seen with a double distal phalanx of the left thumb and hypoplasia of the right thumb. Typical hematological features of the disorder developed, at the age of 2.5 years, about 1 year after diagnosis. Cytogenetic studies confirmed the clinical diagnosis and revealed a spontaneous chromosomal instability and hypersensitivity to the cross-linking agents diepoxybutane and Trenimon. The findings in the patient, who is considered to be the standard for the fifth Fanconi anemia complementation group, are compared with data reported for other patients affected with Fanconi anemia.
Wegner
R D
RD
Institute of Human Genetics, Virchow Klinikum, Humboldt University, Berlin, Germany. rdwegner@ukrv.de
Henrichs
I
I
Joenje
H
H
Schroeder-Kurth
T
T
D002461:Cell Line, Transformed; D002877:Chromosomes, Human / Q000187:drug effects / Q000648:ultrastructure; D003241:Consanguinity; D005199:Fanconi Anemia / Q000097:blood / Q000145:classification / Q000208:ethnology / Q000235:genetics* / Q000473:pathology; D017809:Fatal Outcome; D005385:Fingers / Q000002:abnormalities; D005816:Genetic Complementation Test; D006801:Humans; D007231:Infant, Newborn; D008214:Lymphocytes / Q000648:ultrastructure; D008297:Male; D010641:Phenotype; D014421:Turkey / Q000208:ethnology